Roche’s astegolimab met the main goal of one pivotal COPD study but failed another, mirroring the mixed results recently posted by a Regeneron Pharmaceuticals COPD drug candidate that goes after ...

Roche’s hopes of getting astegolimab to regulators this year took a hit after the anti-ST2 antibody failed to reduce flare-ups in a phase 3 study.

Topline data were announced from two phase 3 trials evaluating astegolimab in patients with moderate to very severe COPD.

COPD rates are higher in rural communities than urban areas, the nonprofit said, and patients may lack easy access to hospitals and other resources.

Singapore’s Land Transport Authority (LTA) has commenced civil construction works for Phase 2 of the Cross Island Line (CRL).

The deep cuts to Medicaid outlined in President Trump’s budget reconciliation bill would hurt Americans suffering from conditions like chronic obstructive pulmonary disease (COPD), Rep. Maxine ...

Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death from disease — on track to be the third by 2035 if nothing changes ...

Scientists have discovered that people with COPD have lung cells that contain over three times as much soot-like carbon as those of smokers without the disease. These overloaded cells are larger ...

Sly Stone died after a prolonged battle with COPD, a lung condition that can be debilitating. Here's what doctors want you to know about it.

Comparable clinical outcomes were found between individuals with airflow obstruction who no longer had COPD per new diagnostic schema and individuals without COPD, according to the study.

The FDA has approved the asthma drug Nucala for adults with chronic obstructive pulmonary disease (COPD).

A GSK drug that targets a pathway behind the lung inflammation in chronic obstructive pulmonary disease, or COPD, has won a long-awaited FDA approval, positioning the biologic medicine to reach ...